​

Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Soleno Therapeutics Ownership Summary

Soleno Therapeutics is owned by 27.01% institutional investors, 1.79% insiders, and 71.21% retail investors. Fmr is the largest institutional shareholder, holding 15.85% of SLNO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in Soleno Therapeutics shares.

SLNO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSoleno Therapeutics27.01%1.79%71.21%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr8.00M15.85%$540.78M
Janus henderson group5.19M12.39%$233.13M
Price t rowe associates inc /md/3.90M7.73%$263.84M
Blackrock funding, inc. /de3.49M6.92%$236.08M
Vanguard group2.81M5.56%$189.76M
Blackrock1.86M5.15%$76.03M
Avoro capital advisors2.58M5.11%$174.26M
Wellington management group llp2.31M4.58%$156.30M
Vivo capital2.28M4.51%$154.01M
State street2.17M4.30%$146.90M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ally bridge group (ny)302.48K12.45%$20.45M
Vivo capital2.28M12.39%$154.01M
Artia global partners lp672.18K7.19%$45.44M
Tri locum partners lp450.58K7.00%$30.46M
Great point partners225.00K6.27%$15.21M
Catalio capital management, lp418.25K5.23%$28.27M
Commodore capital lp1.35M4.46%$91.26M
Ghost tree capital300.00K3.83%$12.24M
Diadema partners lp177.33K3.07%$11.99M
Braidwell lp1.28M2.57%$86.66M

Top Buyers

HolderShares% AssetsChange
Fmr8.00M0.03%4.66M
Wellington management group llp2.31M0.03%1.69M
Blackrock1.86M0.00%1.54M
Braidwell lp1.28M2.57%1.28M
Janus henderson group5.19M0.12%1.11M

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp1.40M0.15%-2.17M
Vivo capital2.28M12.39%-1.68M
Vestal point capital, lp---1.06M
Point72 asset management---916.00K
Carlyle group---860.98K

New Positions

HolderShares% AssetsChangeValue
Braidwell lp1.28M2.57%1.28M$86.66M
Hood river capital management613.39K0.49%613.39K$41.47M
Eventide asset management467.44K0.52%467.44K$31.60M
Logos global management lp350.00K1.84%350.00K$15.73M
Jennison associates349.07K0.01%349.07K$23.60M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Signaturefd-2.00
Stephens consulting-3.00
Ifp advisors-4.00
Cornerstone planning group-4.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025103-60.08%13,634,031-75.97%270.21%72-55.28%21-60.38%
Jun 30, 20252571.58%56,707,4745.32%1120.83%16214.89%51-10.53%
Mar 31, 202526035.42%54,569,8436.92%1180.80%14512.40%59110.71%
Dec 31, 202449-68.59%6,917,396-85.32%160.13%35-66.02%6-75.00%
Sep 30, 202415631.09%47,121,2808.78%1120.79%10330.38%24-4.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.49M2.81%18.04K
T. Rowe Price US All-Cap Opp Eq Comp1.12M2.74%390.37K
T. Rowe Price All-Cap Opportunities Fund1.27M2.38%142.86K
Vanguard US Total Market Shares ETF913.59K1.99%-
iShares Russell 2000 ETF967.86K1.82%-
Polar Capital Biotech S Inc925.00K1.74%107.50K
T. Rowe Price Health Sciences924.65K1.74%338.20K
Janus Henderson Global Life Sciences905.88K1.72%-17.78K
Janus Henderson Global Life Sciences D905.88K1.70%-13.95K
Strategic Advisers Fidelity US TtlStk849.94K1.60%808.44K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 01, 2025Hirano Patricia C SEE REMARKSSell$316.97K
Jun 24, 2025Hirano Patricia C SEE REMARKSSell$22.41K
Apr 01, 2025Hirano Patricia C SEE REMARKSSell$265.16K
Mar 28, 2025Pauls Matthew-Sell$424.80K
Mar 27, 2025Yen Kristen SEE REMARKSSell$116.70K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3-1
2025 Q2-2
2025 Q1-83
2024 Q4-8

SLNO Ownership FAQ

Who Owns Soleno Therapeutics?

Soleno Therapeutics shareholders are primarily institutional investors at 27.01%, followed by 1.79% insiders and 71.20% retail investors. The average institutional ownership in Soleno Therapeutics's industry, Biotech Stocks , is 45.22%, which Soleno Therapeutics falls below.

Who owns the most shares of Soleno Therapeutics?

Soleno Therapeutics’s largest shareholders are Fmr (8M shares, 15.85%), Janus henderson group (5.19M shares, 12.39%), and Price t rowe associates inc /md/ (3.9M shares, 7.73%). Together, they hold 35.97% of Soleno Therapeutics’s total shares outstanding.

Does Blackrock own Soleno Therapeutics?

Yes, BlackRock owns 5.15% of Soleno Therapeutics, totaling 1.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 76.03M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 471.09% change.

Who is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested?

Ally bridge group (ny) is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.45% of its assets in 302.48K Soleno Therapeutics shares, valued at 20.45M$.

Who is the top mutual fund holder of Soleno Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Soleno Therapeutics shares, with 2.81% of its total shares outstanding invested in 1.49M Soleno Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools